- Routine virus testing is effective overall employer strategy for providing employee safety and business continuity
- More research needs to be done on how long vaccines are effective, if booster shots will be needed
- Only 26% of the U.S. is fully vaccinated; vaccinated individuals can still spread the virus
United Medical Equipment Business Solutions Network provides solutions that fit the ever-changing needs of the nation’s workforce during the COVID-19 pandemic through the distribution of rapid antigen tests and COVID-19 rapid kit testing. As employers begin to reopen worksites, routine virus testing is an effective overall strategy for providing employee safety and business continuity.
Chief medical advisor to the president Anthony Fauci, MD, has stated that booster shots for COVID-19 may be needed (https://ibn.fm/NWcBr). The vaccines currently being offered are said to provide protection for at least six months, but more research needs to be done on how long they are effective. The appearance of COVID mutations may also lead to the need for boosters. Right now vaccination efficacy is simply a moving target because the vaccines have not been around long enough to know how long they will be effective fully.
To achieve herd immunity, Fauci has said that the country needs to have 70% to 85% of the country immune either through vaccinations or previous infection. As of April 21, 2020, around 26% of the population was fully vaccinated (https://ibn.fm/w57PZ).
The experts agree that it will take time to suppress the spread entirely. The fact that those who are vaccinated are still capable of spreading the virus to others makes the process even slower; the task becomes even more daunting as fewer Americans practice public health safety measures.
COVID-19 rapid kit testing is needed now more than ever. The pandemic isn’t over, despite the urgency to go back to life as usual. United Medical is making it possible for businesses and health-care facilities to maintain safety and health among workers and clients.
United Medical is a trusted supplier of personal protective equipment (“PPE”) as well as FDA-approved COVID-19 rapid antibody test kits and FDA – EUA authorized rapid antigen tests. The company works with its customers’ specific testing needs and goals to build a customized and flexible employee testing solution that works for the employer, the employees and the customer’s budget.
United Medical is committed to addressing the needs of America’s aging population throughout the global pandemic and far into the future. By offering COVID-19 rapid kit testing, the company is doing its part and continually evolving its efforts to protect the community from COVID-19.
For more information, visit the company’s website at www.UnitedMedSolutions.com.
NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.